Comparison of pre-operative lymphoscintigraphy with inter-operative gamma probe and dye technique regarding the number of detected sentinel lymph nodes

Hellenic Journal of Nuclear Medicine

Volumn 12, Issue 1, 2009, Pages 30-32

  Sadeghi, Ramin ^a   Forghani, Mohammad Naser ^b   Memar, Bahram ^b   Abdollahi, Abbas ^c   Zakavi, Seyed Rasoul ^a   Taghi, Mohammad ^a   Mashhadi, Rajabi ^c   Raziee, Hamid Reza ^b   Tavassoli, Alireza ^c   Dabbagh Kakhki, Vahid Reza ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Lymphoscintigraphy; Sentinel lymph node 99mTC antimony sulfide colloid; Surgical gamma probe

Indexed keywords

ANTIMONY TECHNETIUM SULFIDE TC 99M;

ARTICLE; BREAST CANCER; CANCER SURGERY; CONTROLLED STUDY; ELECTRON PROBE MICROANALYSIS; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; SENTINEL LYMPH NODE; STAINING;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; PREOPERATIVE CARE; RADIONUCLIDE IMAGING; REPRODUCIBILITY OF RESULTS; ROSANILINE DYES; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 64949181540     PISSN: 11081430     EISSN: 17905427     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Krag DN, Anderson SJ, Julian TB et al. Technical outcomes of sentinel lymph node resection and conventional axillary lymph node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 2007; 8: 881-888.
2. Zavagno G, De Salvo GL, Scalco G et al. A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 2008; 247: 207-213.
3. Goyal A, Mansel RE. Recent advances in sentinel lymph node biopsy for breast cancer. Curr Opin Oncol 2008; 20: 621-626.
4. Chicken DW, Keshtgar MR. The emerging role and implications of sentinel node biopsy in breast carcinoma. Hell J Nucl Med 2004; 7: 32-38.
5. Hubalewska-Dydejczyk A, Sowa-Staszczak A, Huszno B. Current application of sentinel lymph node lymphoscintigraphy to detect various cancer metastases. Hell J Nucl Med 2006; 9: 5-9.
6. Aarsvoid JN, Alazraki NP. Update on detection of sentinel lymph nodes in patients with breast cancer. Semin Nucl Med 2005; 35: 116-128.
7. Zanzonico P, Heller S. The intraoperative gamma probe: basic principles and choices available. Semin Nucl Med 2000; 30: 33-48.
8. Turtle TM. Technical advances in sentinel lymph node biopsy for breast cancer. Am Surg 2004; 70: 407-413.
9. Koukouraki S, Sanidas H, Karkabitsas N. Preoperative radionuclide lymphangiography and sentinel node localization with radionuclide techniques. Advantages and ambiguous aspects. Hell J Nucl Med 2004; 7: 5-13.
10. Tanis PJ, Valdes Olmos RA, Muller SH et al. Lymphatic mapping in patients with breast carcinoma: reproducibility of lymphoscintigraphic results. Radiology 2003; 228: 546-551.
11. McMasters KM, Wong SL, Tuttle TM et al. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg 2000; 231: 724-731.
12. Tuthill LL, Reynolds HE, Goulet RJ Jr. Biopsy of sentinel lymph nodes guided by lymphoscintigraphic mapping in patients with breast cancer. Am J Roentgenol 2001; 176: 407-411.
13. Albertini JJ, Cruse CW, Rapaport D et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996; 223: 217-224.
14. Thompson JF, Uren RF, Shaw HM et al. Location of sentinel lymph nodes in patients with cutaneous melanoma: new insights into lymphatic anatomy. J Am Coll Surg 1999; 189: 195-204.
15. 99mTc-antimony sulfide colloid for lymphoscintigraphy. Iran J Nucl Med 2003; 19: 65-57.
16. Buscombe J, Paganelli G, Burak ZE et al. Sentinel node in breast cancer procedural guidelines. Eur J Nucl Med Mol Imaging 2007; 34: 2154-2159.
17. Chagpar AB, Kehdy F, Scoggins CR et al. Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer. Am J Surg 2005; 190: 557-562.
18. Upponi SS, McIntosh SA, Wishart GC et al. Sentinel lymph node biopsy in breast cancer - Is lymphoscintigraphy really necessary? Eur J Surg Oncol 2002; 28: 479-480.
19. Uren RF, Howman-Giles RB, Thompson JF et al. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995; 36: 1775-1783.
20. Mudun A, Aslay I, Aygen M et al. Can preoperative lymphoscintigraphy be used as a guide in treatment planning of breast cancer? Clin Nucl Med 2001; 26: 405-411.
21. Teal CB, Slocum JP, Akin EA, Kelly TA. Correlation of lymphoscintigraphy with the number of sentinel lymph nodes identified intraoperatively in patients with breast cancer. Am J Surg 2005; 190: 567-569.
22. Derossis AM, Fey J, Yeung H et al. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg 2001; 193: 473-478.
23. Feezor RJ, Kasraeian A, Copeland EM et al. Sequential dermal-peritumoral radiocolloid injection for sentinel node biopsy for breast cancer: the University of Florida experience. Am Surg 2002; 68: 684-688.
24. Rovera F, Frattini F, Marelli M et al. Axillary sentinel lymph node biopsy: An overview. Int J Surg 2008; Epub 2008 Dec 13.
25. Beslić N. The role of sentinel lymph node detection in management of patients with breast cancer. Med Arh 2008; 62: 240-241.